Zobrazeno 1 - 10
of 69
pro vyhledávání: '"KLR Brouwer"'
Publikováno v:
BMC Medical Education, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Postdoctoral trainees play a vital role in securing grant funding, building alliances, and mentoring graduate students under the guidance of a mentor who can help develop their intellectual independence. However, the experiences o
Externí odkaz:
https://doaj.org/article/51d1a73aee614ba8a40a63cb788e56a2
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Altered expression and function of transporters in nonalcoholic steatohepatitis (NASH) patients may affect the pharmacokinetics (PK), efficacy, and safety of substrate drugs. A population pharmacokinetic (PopPK) analysis was performed to assess diffe
Autor:
Vujic E; Curriculum in Toxicology & Environmental Medicine, School of Medicine, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ferguson SS; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Curriculum in Toxicology & Environmental Medicine, School of Medicine, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2024 Aug 01; Vol. 200 (2), pp. 213-227.
Autor:
Hartauer M; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Murphy WA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Southall R; Simcyp Division, Certara UK Ltd, Sheffield, UK., Neuhoff S; Simcyp Division, Certara UK Ltd, Sheffield, UK.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jun 19. Date of Electronic Publication: 2024 Jun 19.
Autor:
Galetin A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester, Manchester, UK. Aleksandra.Galetin@manchester.ac.uk., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tweedie D; Independent Consultant, Guilford, CT, USA., Yoshida K; Clinical Pharmacology, Genentech Research and Early Development, South San Francisco, CA, USA., Sjöstedt N; Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Aleksunes L; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA., Chu X; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, NJ, USA., Evers R; Preclinical Sciences and Translational Safety, Johnson & Johnson, Janssen Pharmaceuticals, Spring House, PA, USA., Hafey MJ; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, NJ, USA., Lai Y; Drug Metabolism, Gilead Sciences Inc., Foster City, CA, USA., Matsson P; Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Riselli A; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Shen H; Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb Research and Development, Princeton, NJ, USA., Sparreboom A; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Varma MVS; Pharmacokinetics, Dynamics and Metabolism, Medicine Design, Worldwide R&D, Pfizer Inc, Groton, CT, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Yang X; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Zamek-Gliszczynski MJ; Drug Metabolism and PK, GlaxoSmithKline, Collegeville, PA, USA., Zhang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Giacomini KM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA. Kathy.Giacomini@ucsf.edu.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Apr; Vol. 23 (4), pp. 255-280. Date of Electronic Publication: 2024 Jan 24.
Autor:
Adiwidjaja J; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Simulations Plus, Inc, Lancaster, CA, USA., Spires J; Simulations Plus, Inc, Lancaster, CA, USA. jessica.spires@simulations-plus.com., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. kbrouwer@unc.edu.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Mar; Vol. 41 (3), pp. 441-462. Date of Electronic Publication: 2024 Feb 13.
Autor:
Murphy WA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Diehl AM; Division of Gastroenterology and Hepatology, Duke University Medical Center, Durham, North Carolina, USA., Loop MS; Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, Alabama, USA., Fu D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Guy CD; Department of Pathology, Duke University, Durham, North Carolina, USA., Abdelmalek MF; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Karachaliou GS; Division of Gastroenterology and Hepatology, Duke University Medical Center, Durham, North Carolina, USA., Sjöstedt N; Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Neuhoff S; Simcyp Division, Certara UK Ltd., Sheffield, United Kingdom., Honkakoski P; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Hepatology communications [Hepatol Commun] 2024 Feb 14; Vol. 8 (3). Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Autor:
Jeong A; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 100 L Beard Hall, CB# 7569, Chapel Hill, NC, 27599-7569, USA., Pastor CM; Centre de recherche sur l'inflammation, Université de Paris, Inserm, U1149, CNRS, ERL8252, F-75006, Paris, France., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 100 L Beard Hall, CB# 7569, Chapel Hill, NC, 27599-7569, USA. kbrouwer@unc.edu.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Nov; Vol. 40 (11), pp. 2513-2523. Date of Electronic Publication: 2023 Jun 22.
Autor:
Saran C; Transporter Sciences, Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics (PDMB), Merck & Co., Inc., West Point, Pennsylvania, USA., Brouwer KLR; UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2023 Oct; Vol. 51 (7-8), pp. 405-413. Date of Electronic Publication: 2023 Nov 20.
Autor:
Saran C; Department of Pharmacology, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, United States.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States., Ho H; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States., Honkakoski P; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States.; School of Pharmacy, University of Eastern Finland, Kuopio, Finland., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Mar 22; Vol. 14, pp. 1147495. Date of Electronic Publication: 2023 Mar 22 (Print Publication: 2023).